Limitations to the feasibility of discordant liver transplantation.
Schraa
E O
EO
Department of Surgery, Erasmus University Rotterdam, The Netherlands.
Scheringa
M
M
Buchner
B
B
Marquet
R L
RL
LJzermans
J N
JN
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis; D003169:Complement Inactivator Proteins / Q000627:therapeutic use; D006224:Cricetinae; D004546:Elapid Venoms / Q000627:therapeutic use; D005240:Feasibility Studies; D005260:Female; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology; D008647:Mesocricetus; D013156:Splenectomy; D014183:Transplantation, Heterologous / Q000276:immunology / Q000473:pathology
D000910:Antibodies, Heterophile; D003169:Complement Inactivator Proteins; D004546:Elapid Venoms; C016310:cobra venom factor